Professor David Goldblatt (UCL GOS Institute of Child Health) led research which has informed the Joint Committee on Vaccination and Immunisation’s decision to reduce the dosage of the pneumococcal conjugate vaccine (PCV) from three doses to two.
Read: Telegraph